Jenny Wissmar
BioPharmaceuticals R&D, Respiratory And Immunology, AstraZeneca
Goeteborg, O, Sweden
Goeteborg, O, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: A Randomized, Phase 3 Study.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: October 31, 2025
Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: the Randomized, Phase 3, TULIP-SC Study.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: October 31, 2025
Development Strategy and Relative Bioavailability of a Pediatric Tablet Formulation of Ticagrelor.
Journal: Clinical drug investigation
Published: May 30, 2019
A dose-ranging study of ticagrelor in children aged 3-17 years with sickle cell disease: A 2-part phase 2 study.
Journal: American journal of hematology
Published: June 25, 2018
Diagnosis of gastro-oesophageal reflux disease is enhanced by adding oesophageal histology and excluding epigastric pain.
Journal: Alimentary pharmacology & therapeutics
Published: December 08, 2016
Epithelial Thickness is a Marker of Gastroesophageal Reflux Disease.
Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Published: September 28, 2015
Sleep disturbance due to heartburn and regurgitation is common in patients with functional dyspepsia.
Journal: United European gastroenterology journal
Published: March 04, 2015
Efficacy and safety of rosuvastatin therapy in children and adolescents with familial hypercholesterolemia: Results from the CHARON study.
Journal: Journal of clinical lipidology
Published: November 11, 2014
Effect of CYP2C19 polymorphism on the pharmacokinetics of rosuvastatin in healthy Taiwanese subjects.
Journal: Clinical pharmacology in drug development
Published: November 07, 2013
Showing 1-9 of 9
Last Updated: 09/26/2026